Fig. 1From: Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver diseaseComparison of plasma levels of FAM19A5 between control and NAFLD groups. Concentration of FAM19A5 in plasma measured by ELISA; differences between the groups were analyzed with Mann-Whitney U; *indicates p < 0.05Back to article page